---
title: "ANYKA MICROELECTRONICS released its semi-annual performance, with a net loss attributable to the parent company of 49.25 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/252860309.md"
description: "ANYKA MICROELECTRONICS released its semi-annual report for 2025, with revenue of 234 million yuan, a year-on-year decrease of 3.02%. The net loss attributable to the parent company was 49.25 million yuan, and the net profit excluding non-recurring items was a loss of 49.33 million yuan, with basic earnings per share of -0.13 yuan. Despite an increase in the shipment volume of chip products and maintaining market share, intensified competition in the semiconductor industry and price pressure on certain products led to a decline in overall gross margin. The company continues to increase R&D investment to enhance technological advantages and expand the market"
datetime: "2025-08-13T12:08:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/252860309.md)
  - [en](https://longbridge.com/en/news/252860309.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/252860309.md)
---

# ANYKA MICROELECTRONICS released its semi-annual performance, with a net loss attributable to the parent company of 49.25 million yuan

According to the Zhitong Finance APP, ANYKA MICROELECTRONICS (688620.SH) disclosed its semi-annual report for 2025, showing that the company achieved revenue of 234 million yuan during the reporting period, a year-on-year decrease of 3.02%; the net loss attributable to shareholders of the listed company was 49.25 million yuan; the net profit excluding non-recurring items was a loss of 49.33 million yuan; basic earnings per share were -0.13 yuan.

During the reporting period, the company's chip product shipments increased, maintaining market share; however, intensified competition in certain markets of the semiconductor industry continued to impact, leading to price pressure on some products and a year-on-year decline in overall gross margin; to continuously enhance technological advantages and expand product/market layout, the company maintained a stable slight increase in R&D investment

### Related Stocks

- [688620.CN](https://longbridge.com/en/quote/688620.CN.md)

## Related News & Research

- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [10:19 ETAARC-360 Completes AICPA Peer Review with Pass Rating](https://longbridge.com/en/news/286929747.md)
- [Russia plans to return staff to Iranian Bushehr nuclear plant in coming weeks, RIA reports](https://longbridge.com/en/news/286905394.md)
- [13:41 ETUT Haslam Marks Decade in Major International Ranking's Top Five U.S. Public Schools](https://longbridge.com/en/news/286804132.md)
- [ZAWYA: Joramco rewards employees with up to 12 weeks’ bonus](https://longbridge.com/en/news/287035395.md)